Loading...
•
Dec 31, 2019
Bruker Q4 2019 Earnings Report
Bruker's Q4 2019 financial results were announced, revealing an increase in revenue and operating income compared to the previous year, although EPS declined due to a higher effective tax rate.
Key Takeaways
Bruker Corporation reported an 8.4% increase in revenue for Q4 2019, reaching $599.9 million. GAAP operating income was $117.7 million, with a margin of 19.6%. However, GAAP EPS decreased to $0.44, and non-GAAP EPS decreased to $0.53, driven by a higher effective tax rate.
Q4 2019 revenue increased by 8.4% to $599.9 million.
Organic revenue growth for Q4 2019 was 5.2%.
GAAP operating income for Q4 2019 was $117.7 million, representing a 19.6% margin.
GAAP EPS for Q4 2019 was $0.44, while non-GAAP EPS was $0.53.
Bruker
Bruker
Forward Guidance
Due to the challenging business conditions created by the global spread of COVID-19, Bruker is suspending its guidance for FY 2020. The Company expects to provide a business update on its first quarter 2020 earnings conference call in early May 2020.
Positive Outlook
- Bruker contributes to global healthcare.
- Bruker contributes to food supply.
- Bruker contributes to IT infrastructure.
- Bruker contributes to homeland security.
- Bruker continues to have a solid balance sheet and a strong liquidity position.
Challenges Ahead
- Bruker is suspending its guidance for FY 2020.
- Both revenue and earnings will be lower in the first quarter of 2020 than in the first quarter of 2019.
- The Company’s second quarter 2020 results are expected to be significantly negatively impacted by COVID-19 related disruptions to the Company’s operations
- The Company’s second quarter 2020 results are expected to be significantly negatively impacted by COVID-19 related disruptions to customer operations
- The Company’s second quarter 2020 results are expected to be significantly negatively impacted by COVID-19 related disruptions to global supply chains and logistics.